Table 1.

Clinical characteristics of the study sample.

Patient Characteristics (N = 30)
Age, mean(SD), years	67.9 (8.85)
Sex - Male no (% of total).	21.0 (70%)
BMI mean(SD) [kg/m²]	26.9 (5.3)
Anesthesia & Surgery Data
Duration of anesthesia; mean(SD) [min]	389.3 ± 89.07
Duration of surgery; mean(SD) [min]	272.1 ± 83.2
Duration of CBP, mean(SD) [min]	123.5 ± 56.5
Duration of X-clamp, mean(SD) [min]	80.2 ± 44.4
Coronary artery bypass surgery no. (% of total).	10 (33%)
Mitral valvuloplasty no. (%ana of total).	8 (26.7%)
Aortic valve replacement no. (% of total).	7 (23.3%)
Aortic aneurysm repair no. (% of total).	2 (6.7%)
Others, no (% of total).	3 (10%)
Opioid/Sedative Usage
During Surgery
Morphine Equivalents, mean(SD) [mg]	120.3 ± 42.6
Midazolam, mean(SD) [mg]	4.4 ± 2.1
Corticosteroid Administration (% of all cases)	10
In 24 h post-surgery
Morphine Equivalents, mean(SD) [mg]	32.4 ± 38.8
Midazolam, mean(SD) [mg]	1.2 ± 4.3
Aspirin Administration (% of all cases)	60
Ketorolac Administration (% of all cases)	3.3
Transfusions
During surgery
Packed Red Blood Cells, mean (CI95%) [ml]	0 (0;1200)
Fresh Frozen Plasma, mean (CI95%) [ml]	0 (0;2250)
Platelets, mean (CI95%) [ml]	0 (0;1032)
In 24 h post-surgery
Packed Red Blood Cells, mean; (CI95%) [ml]	0 (0;600)
Fresh Frozen Plasma, mean; (CI95%) [ml]	0 (0;900)
Platelets, mean; (CI95%) [ml]	0 (0;900)
Total Crystalloid during surgery[ml]	2500 (400;5200)
ICU stay
APACHE score at 1 h, mean(SD)	20.5 (4.8)
APACHE score at 24 h, mean(SD)	12.0 (4.9)
APACHE score at 48 h, mean(SD)	12.1 (5.7)
Comorbidities
Acute Coronary Syndrome	9 (30.0%)
Chronic heart failure	5 (16.7%)
Connective tissue disease (non-active)	5 (16.7%)
Peripheral vascular disease	3 (10.0%)
Cerebrovascular disease	4 (13.3%)
Type 2 diabetes	1 (3.3%)
Liver disease	0 (0%)
AIDS	0 (0%)
COPD	1 (3.3%)
Any tumor (last five years)	1 (3.3%)
Renal failure (moderate-severe)	5 (16.7%)